FNY Partners Fund’s Regenxbio RGNX Stock Holding History

FNY Partners Fund’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,500	Closed	-$48K	–	1033
2017 Q1	$48K	Buy	+2,500	New	+$48.2K	0.01%	729

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FNY Partners Fund's RGNX Position: Q2 2017 in Review

FNY Partners Fund sold out of Regenxbio (RGNX) in Q2 2017, closing a stake of 2,500 shares — an estimated $48K sold.

FNY Partners Fund first reported a position in RGNX in Q1 2017 and held it in 1 quarter. The position peaked at $48K in Q1 2017. 86 funds tracked by Wall St. Rank hold RGNX as of Q2 2017.

FNY Partners Fund reported no remaining Regenxbio position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 2,500 Regenxbio shares in Q2 2017, an estimated $48K.
FNY Partners Fund first reported a position in Regenxbio in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Regenxbio position peaked at $48K in Q1 2017.
86 funds tracked by Wall St. Rank held Regenxbio as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.